Tuttle Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-5,754
Closed -$455K 238
2020
Q3
$455K Buy
+5,754
New +$451K 0.31% 78
2020
Q1
Sell
-8,791
Closed -$763K 105
2019
Q4
$763K Buy
8,791
+5,798
+194% +$476K 0.29% 80
2019
Q3
$247K Sell
2,993
-15,406
-84% -$1.23M 0.07% 217
2019
Q2
$1.47M Buy
18,399
+5,784
+46% +$443K 0.58% 50
2019
Q1
$1M Buy
12,615
+2,907
+30% +$217K 0.2% 117
2018
Q4
$708K Sell
9,708
-12,929
-57% -$913K 0.27% 73
2018
Q3
$1.53M Buy
+22,637
New +$1.44M 0.29% 86
2017
Q3
Sell
-13,291
Closed -$812K 94
2017
Q2
$812K Sell
13,291
-3,028
-19% -$184K 0.63% 30
2017
Q1
$988K Buy
+16,319
New +$990K 1.19% 12

Other funds holding MRK

Tuttle Capital Management's MRK Position: Q4 2020 in Review

Tuttle Capital Management sold out of Merck (MRK) in Q4 2020, closing a stake of 5,754 shares — an estimated $455K sold.

Tuttle Capital Management first reported a position in MRK in Q1 2017 and held it in 9 quarters. The position peaked at $1.53M in Q3 2018. 2,709 funds tracked by Wall St. Rank hold MRK as of Q4 2020.

  • Tuttle Capital Management reported no remaining Merck position as of Q4 2020 after selling out during the quarter.
  • Tuttle Capital Management sold 5,754 Merck shares in Q4 2020, an estimated $455K.
  • Tuttle Capital Management first reported a position in Merck in Q1 2017 and held it in 9 quarters.
  • Tuttle Capital Management's Merck position peaked at $1.53M in Q3 2018.
  • 2,709 funds tracked by Wall St. Rank held Merck as of Q4 2020.

Based on Tuttle Capital Management's 13F filing for Q4 2020, filed 20 Jan 2021.